Skip to main content

ACE/ARB Therapy at Discharge for ICD implant patients with Left Ventricular Systolic Dysfunction

CBE ID
1522
1.4 Project
Cardiovascular
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2015
Is Under Review
No
1.3 Measure Description

Proportion of ICD implant patients with a diagnosis of LVSD who are prescribed ACE-I or ARB therapy at discharge.

    • 1.14 Numerator

      Count of patients with ACE-I or ARB therapy prescribed at discharge.

    • 1.15 Denominator

      1) Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ACE inhibitors who do not have a contraindication to ACE inhibitors documented
      AND
      2)Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ARB therapy who do not have a contraindication to ARB therapy documented

    • Exclusions

      Discharge status of expired
      Contraindicated or blinded to both ACE inhibitors and ARB therapy

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cardiovascular Project 2015-2016
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      American College of Cardiology
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      © 2010 American College of Cardiology Foundation All Rights Reserved